Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for SunWay Biotech Co., LTD. (1271.TWO), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
26.26
P/B ratioShare price divided by book value per share.
0.91
P/S ratioMarket value divided by annual revenue.
2.33
PEG ratioP/E divided by the earnings growth rate.
0.38
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
30.06
EV / RevenueEnterprise value against annual revenue.
3.01
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
3.81%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
46.88%
Operating marginRevenue left after operating costs.
5.01%
Net marginRevenue left after every cost, including tax and interest.
8.90%
Return on equityProfit as a percentage of shareholders’ equity.
3.69%
Return on assetsProfit as a percentage of total assets.
1.09%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
1.49
Quick ratioThe same, excluding inventory.
0.92
Debt to equityTotal borrowings against shareholders’ equity.
0.37
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$2.27
Book value per shareShareholders’ equity divided by shares outstanding.
$65.24
Shares outstandingShares currently issued.
60,088,066
Market capitalisationShare price times shares outstanding.
$3.58B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
1.31%
Payout ratioShare of profit paid out as dividends.
SunWay Biotech Co., LTD. (1271.TWO) trades on a price-to-earnings ratio of 26.26.
What is SunWay Biotech Co., LTD.'s return on equity?
SunWay Biotech Co., LTD. (1271.TWO) reports a return on equity of 3.69%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does SunWay Biotech Co., LTD. carry?
SunWay Biotech Co., LTD. (1271.TWO) has a debt-to-equity ratio of 0.37, which compares total borrowings with shareholders' equity.
What is SunWay Biotech Co., LTD.'s profit margin?
SunWay Biotech Co., LTD. (1271.TWO) keeps 8.90% of revenue as net profit after every cost, including tax and interest.